White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F
Deficiency of Electron Transport Chain in Human Skeletal Muscle Mitochondria in Type 2 Diabetes Mellitus and Obesity
Lessons From GLP-1/Glucagon Co-Agonists in Clinical Development The first GLP-1/glucagon co-agonist to advance to human clinical trials was cotadutide (MEDI0832)
Theres also an opportunity in testosterone-boosting supplements to add ingredients that can account for the potential adverse effects of others
Figures for semaglutide and tirzepatide have been derived from published cardiovascular outcome trials
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial